Quantbot Technologies LP Grows Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Quantbot Technologies LP boosted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 65.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,116 shares of the company’s stock after buying an additional 2,018 shares during the quarter. Quantbot Technologies LP’s holdings in Phibro Animal Health were worth $107,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Rhumbline Advisers grew its stake in shares of Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after acquiring an additional 484 shares during the period. Los Angeles Capital Management LLC raised its stake in Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after buying an additional 503 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after buying an additional 729 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after buying an additional 775 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after acquiring an additional 906 shares during the period. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

Shares of PAHC opened at $21.36 on Tuesday. The business has a 50-day simple moving average of $22.79 and a two-hundred day simple moving average of $22.69. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a 52 week low of $12.17 and a 52 week high of $26.55. The stock has a market cap of $865.14 million, a price-to-earnings ratio of 44.50, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent research reports. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. Finally, Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.